← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Jt Pharmaceuticals, Inc.
Mount Pleasant, SC
$6,192,935
Total funding
5
Grants
Funding over time
peak $1.4M · FY2014–19$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$6,192,935 · 5
By mechanism
R44$4,143,784 · 2
R42$1,500,000 · 1
R43$549,151 · 2
Investigators at Jt Pharmaceuticals, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Stroke Treatment by Chemically-induced Hypothermia$965,517
R44 · FY2019 · NS
Stroke Treatment by Chemically-induced Hypothermia$965,517
R44 · FY2017 · NS
Stroke Treatment by Chemically-induced Hypothermia$965,515
R44 · FY2018 · NS
Stroke Treatment by Chemically-induced Hypothermia$793,793
R42 · FY2015 · NS
Stroke Treatment by Chemically-induced Hypothermia$706,207
R42 · FY2016 · NS
Development of a Neurotensin Fragment for Neuropathic Pain$647,660
R44 · FY2015 · NS
Development of a Neurotensin Fragment for Neuropathic Pain$599,575
R44 · FY2016 · NS
Engineered Neurotensin Fragments Targeting Neuropathic Pain$324,258
R43 · FY2014 · DE
Peptide-Derived Orally-Active Kappa-Opioid Receptor Agonists for Peripheral Pain$224,893
R43 · FY2014 · DA